Your Biological Age vs. Your Real Age: What Biomarkers Like GrimAge, PhenoAge and DunedinPace Actually Tell You

You may be 52 by the calendar, while a biological-age test gives a different estimate. That number depends on which test was used and what it was trained to predict. DNA-methylation clocks estimate aspects of aging from patterns of chemical marks on DNA; some were designed to predict age, others health risk or pace of change 111226.

This article explains what those estimates can tell you, what remains uncertain, and how to interpret lifestyle research without confusing a changed biomarker with proven extra years of healthy life 27.

Your chronological age is the number of years since birth. It is an important health predictor, but people of the same age can differ in health and function. Biological-age measures aim to capture some of those differences. Researchers study several kinds of markers, including blood metabolites and DNA methylation 2412. Epigenetic clocks add useful research tools; no single clock captures the whole body or determines an individual future 1226.

Epigenetic clocks use patterns of DNA methylation at selected sites as inputs to statistical models. The resulting score depends on the model’s target and the population used to develop it. DNAm PhenoAge was trained through a clinical phenotype and uses 513 methylation sites; GrimAge combines methylation-based surrogates with age and sex to estimate mortality-related risk 1112.

Some methylation-based measures predict health outcomes beyond chronological age in the populations studied. This does not make a result a precise measurement of your entire body’s age or remaining lifespan. Interpret the specific clock, its purpose and its limits 111226.

Early clocks, including the 2013 Horvath and Hannum clocks, were trained to estimate chronological age from DNA methylation. Later clocks used health-related targets to improve prediction of outcomes beyond calendar age 12. Accuracy and clinical meaning depend on the clock, tissue, population and outcome; a single correlation does not establish a universal ranking.

DNAm PhenoAge (Morgan Levine and colleagues) inverted the approach 11. Researchers first built a composite phenotypic age from nine clinical biomarkers — albumin, creatinine, glucose, C-reactive protein, white cell count among them — plus chronological age, chosen because the composite strongly predicts mortality. They then trained the clock to predict that, not calendar age.

The result tracks biological aging as it relates to health outcomes: higher PhenoAge acceleration predicts all-cause mortality, cancer, physical disability, and immune and metabolic dysfunction, independent of chronological age 11.

DNAm GrimAge (Ake Lu and colleagues) was trained to predict mortality using DNA-methylation surrogates for seven plasma proteins and smoking pack-years, together with age and sex 12.

AgeAccelGrim is the deviation of the GrimAge estimate after adjustment for chronological age. It is associated with outcomes in validation cohorts; it is not a direct measurement of how fast an individual is aging or a prediction of their date of death 12.

DunedinPACE, developed from the Dunedin birth cohort in New Zealand, estimates the pace of aging-related change from a blood DNA-methylation sample 26. It was trained using longitudinal change in 19 physiological indicators across ages 26, 32, 38 and 45. A value near 1 represents the average pace in the training cohort, not an exact personal stopwatch.

In the CALERIE randomized trial, calorie restriction produced a small average change in DunedinPACE, without a corresponding effect on the PhenoAge and GrimAge measures studied 27. These biomarkers are useful research outcomes; changing a score does not yet establish additional years of life.

Validation studies associate DNAm GrimAge with mortality, coronary heart disease and cancer, and DNAm PhenoAge with mortality and several health and function outcomes 1112. The strength of prediction depends on the population, outcome, clock and statistical adjustment. An association in a cohort does not diagnose disease or predict when an individual will die.

In a cohort of Danish twins aged 70 and older, perceived age from photographs was associated with survival and with telomere length after adjustment for chronological age and sex 17. This population association is not a personal prognosis or evidence that changing appearance prolongs life.

Lifestyle and health factors can correlate with biological-age measures, but associations differ between clocks. They do not all establish that changing one factor will reverse biological aging 131823.

Smoking is relevant to some methylation-based measures. GrimAge explicitly includes a methylation-based surrogate for smoking pack-years. That does not establish smoking as the single strongest accelerator across every clock, or turn the score into a direct measurement of accumulated damage 12.

Higher BMI has been associated with higher epigenetic-age measures, including in the Women’s Health Initiative analysis. These observational relationships can be affected by metabolic health and other differences between participants 18.

Inflammation-related information contributes to some aging measures. The original clinical PhenoAge model includes C-reactive protein. A contribution to a predictive model does not prove that lowering that marker alone will slow aging 11.

Glucose is one of the laboratory measures in the clinical PhenoAge model. That fact should not be interpreted as proof that each post-meal glucose rise accelerates an epigenetic clock, or as a reason to diagnose aging from a glucose reading alone 11.

A systematic review examined associations between physical capacity and biological-age measures across 28 studies. Its evidence concerns measured associations and varied biomarkers; it does not establish a universal exercise dose that reverses biological age 23.

Intervention research is developing. Observational associations and changes in aging biomarkers should be distinguished from demonstrated reductions in disease or mortality 2227.

A systematic review included 13 studies and 5,043 participants, with a narrative synthesis rather than a meta-analysis. Seven studies used telomere length, five used cognitive measures, and one used the Horvath epigenetic clock. The limited and varied evidence does not establish a dietary protocol that reverses epigenetic aging 22.

In an observational analysis, diet and lifestyle associations differed by clock. Fish intake was associated with lower extrinsic epigenetic age acceleration in some analyses; this does not establish that fish or a supplement slows aging 18. Alcohol and smoking have also been studied in relation to methylation-based aging, with results that depend on the measure and design 16.

The following are illustrative meal-planning ideas, not a tested biological-age intervention. Portions are examples to adapt to appetite, needs and preferences.

Physical capacity and biological-age measures are associated in observational research 23. WHO recommends at least 150 minutes of moderate aerobic activity weekly, with additional benefits up to 300 minutes, and muscle-strengthening activities on two or more days 28. These are general health recommendations, not a proven prescription for reversing epigenetic age. Adapt activity to individual ability and clinical advice.

Resting heart rate can help monitor fitness and heart health, but it is not a direct measure of biological aging. For many adults, 60–100 beats per minute is a normal resting range; trained athletes may be lower. Medication, illness and other factors also affect pulse 25. A value below 60–65 is not a universal goal, and unexplained changes or symptoms deserve clinical assessment.

A study using skin, oral and gut microbiomes predicted chronological age, not a validated measure of biological aging. Average prediction errors were about 3.8 years for skin and 11.5 years for gut samples 15. These results do not show that changing the microbiome makes a person biologically younger.

Epigenetic results deserve scientific humility:

1. Population-level tools. Associations in cohorts do not make an individual result exact. Technical and biological variability matter; comparisons require consistent methods 26.
2. Association is not causation. Whether lowering an aging-marker score improves lifespan remains unproven 27.
3. Test details matter. Ask which clock, sample type and analysis were used, and discuss interpretation with a qualified healthcare professional.
4. Clock choice matters. GrimAge was developed for mortality-related prediction, while DunedinPACE estimates a pace measure. Neither is a personal prognosis 1226.
5. Intervention evidence is specific. CALERIE found a modest average effect on DunedinPACE, not on the PhenoAge or GrimAge measures studied. It did not demonstrate age reversal or longer lifespan 27. Calorie restriction should be assessed for nutritional adequacy and individual medical suitability.

The practical message is broader than a single biomarker number. Lifestyle and health factors are associated with some aging measures, but the relationships differ by clock and study design 1823. Intervention evidence is still developing: CALERIE found a modest change in DunedinPACE after calorie restriction, without a corresponding change in the other two methylation-age measures tested 27.

Use established health guidance, including regular physical activity, as the basis for action 28. Treat clock results as supplementary information and discuss meaningful changes in context. A lower number is not yet proof that an intervention has extended your life 27.

• Different targets: PhenoAge, GrimAge and DunedinPACE estimate different aspects of aging from DNA methylation. Their outputs are not interchangeable 111226.
• Prediction has limits: Health-outcome associations do not make a clock an exact personal prognosis 1226.
• Lifestyle findings vary: Associations depend on the clock, population and study design; they do not all establish a causal effect of changing one behavior 131823.
• Diet evidence remains limited: The nutrition review covered varied biomarkers and only one epigenetic-clock study, so it cannot validate a diet for age reversal 22.
• Intervention results are specific: CALERIE found a modest change in DunedinPACE, without a demonstrated lifespan benefit 27.
• Act on established health guidance: Regular activity has recommended targets for health; these are not guarantees of a younger clock score 28. Interpret an individual test with its method, limitations and clinical context in mind 2627.